Genethon receives the 2012 Prix Galien France for its innovative treatments of rare diseases using gene therapy and awarded it the prize in the category of “Medicines destined for rare diseases – cell therapy and gene therapy.”
For the first time, a non-profit organization, created by a patient association, has received the Prix Galien France.
Read the press release – 04/10/2012 (1 page – 90ko)
